MedTrace Logo

Topical Vitamin E Ovules for the Treatment of Hemorrhoids

NCT04362384 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-04-24

No results posted yet for this study

Summary

Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups:

* Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus
* Control group: Patients will receive a treatment with corticoid ointment, with endoanal application

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment.

Conditions

  • Bleeding Anal
  • Pain
  • Stings

Interventions

DRUG

Vitamin E ovules

Endoanal vitamin E ovules will be prescribed

DRUG

Prednisolone ointment

Endoanal Prednisolone ointment will be prescribed

Sponsors & Collaborators

  • Hospital General Universitario Elche

    lead OTHER

Principal Investigators

  • Jaime Ruiz Tovar Polo · Garcilaso Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-10-30
Completion
2020-10-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04362384 on ClinicalTrials.gov